Search Results
Found 1 results
510(k) Data Aggregation
(57 days)
EXTRA-ANATOMICAL VASCULAR REPAIR PRIMARILY FOR AXILLO-FEMORAL/BIFEMORAL BYPASS AND FEMORO-POPLITEAL RECONSTRUCTION
VASCUTEK GELSOFT PLUS ERS VASCULAR GRAFT
The provided documents are a letter from the FDA regarding a 510(k) premarket notification for the "Vascutek Ltd. Gelsoft Plus ERS" vascular prosthesis, and an "Indications for Use" statement. These documents do not contain any information about acceptance criteria, device performance studies, sample sizes, expert qualifications, ground truth establishment, or multi-reader multi-case studies.
The letter is a regulatory approval document stating that the device is substantially equivalent to legally marketed predicate devices, allowing it to be marketed. It focuses on regulatory compliance rather than providing detailed study data.
To answer your request, I would need a different set of documents, specifically those related to the performance studies conducted for the Vascutek Gelsoft Plus ERS vascular graft.
Ask a specific question about this device
Page 1 of 1